Skip Navigation

This Article
Right arrow Print PDF (1780K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Miles, J.S.
Right arrow Articles by Wolf, C.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, J.S.
Right arrow Articles by Wolf, C.R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1989, Vol. 17, No. 20 8241-8255
© 1989

MOLECULAR BIOLOGY

Alternative splicing in the human cytochrome P450IIB6 gene generates a high level of aberrant messages

J.S. Miles, A.W. McLaren and C.R. Wolf*

Imperial Cancer Research Fund, Laboratory of Molecular Pharmacology and Drug Metabolism, University Department of Biochemistry Hugh Robson Building, George Square, Edinburgh EH8 9XD, UK

*To whom correspondence should be addressed

Received August 18, 1989. Accepted September 15, 1989.

Polymorphisms within the human cytochrome P450 system can have severe clinical conaequences and have been associated with adverse drug side effects and susceptibility to environmentally linked diseases such as cancer. Aberrant splicing of cytochrome P450 mRNA has been proposed as a potential mechanism for these polymorphisms. we have isolated aberrantly, as well aa normally, spliced mRNAa (cDNAs) from the human P450IIB6 gene which either contain part of intron 5 and lack exon 8 or which contain a 58-bp fragment (exon 8A) instead of exon 8. Sequence analysis of the P450IIB6 gene demonstrates the presence of cryptic splice sites in intron 8 which will account for the generation of exon 8A. The mRNAs were therefore generated by alternative splicing. These data gain significance as the mRNAs will not encode a functional P450 enzyme and appear to represent a high proportion of the P450IIB6 mRNA population. Analysis of mRNA from fifteen individual human livers and cDNA libraries constructed from a variety of human tissues using the polymerase chain reaction shows that the aberrant splicing occurs in all cells and all individuals tested. This suggests a high level of infidelity in the processing of P450II56 mRNAs and demonstrates that the presence of abnormal transcripts does not imply the presence of a functionally inactive gene.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
M. H. Hofmann, J. K. Blievernicht, K. Klein, T. Saussele, E. Schaeffeler, M. Schwab, and U. M. Zanger
Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 284 - 292.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. M. Jacob, E. C. Johnstone, M. J. Neville, and R. T. Walton
Identification of CYP2B6 Sequence Variants by Use of Multiplex PCR with Allele-Specific Genotyping
Clin. Chem., August 1, 2004; 50(8): 1372 - 1377.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. Lamba, J. Lamba, K. Yasuda, S. Strom, J. Davila, M. L. Hancock, J. D. Fackenthal, P. K. Rogan, B. Ring, S. A. Wrighton, et al.
Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 906 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. R. Faucette, R. L. Hawke, E. L. Lecluyse, S. S. Shord, B. Yan, R. M. Laethem, and C. M. Lindley
Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity
Drug Metab. Dispos., October 1, 2000; 28(10): 1222 - 1230.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Christmas, J. P. Jones, C. J. Patten, D. A. Rock, Y. Zheng, S.-M. Cheng, B. M. Weber, N. Carlesso, D. T. Scadden, A. E. Rettie, et al.
Alternative Splicing Determines the Function of CYP4F3 by Switching Substrate Specificity
J. Biol. Chem., October 5, 2001; 276(41): 38166 - 38172.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.